Clinical Experience of Neratinib in the Treatment of HER-2 Overexpressed Refractory Metastatic Breast Cancer

ZHNG Sho-hu;JING Ze-fei;SONG Sn-ti;CO Yng;YUN Yng;WNG To;WU Shi-ki;ZENG Min;HUNG Hong-yn;IN Li;DU Meng

Chinese Pharmaceutical Journal ›› 2011, Vol. 46 ›› Issue (24) : 1956-1958.

PDF(431 KB)
PDF(431 KB)
Chinese Pharmaceutical Journal ›› 2011, Vol. 46 ›› Issue (24) : 1956-1958.

Clinical Experience of Neratinib in the Treatment of HER-2 Overexpressed Refractory Metastatic Breast Cancer

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2011, 46(24): 1956-1958

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(431 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉